Pharmacoepidemiology and Drug Safety

Cover image for Vol. 21 Issue 11

November 2012

Volume 21, Issue 11

Pages 1139–1249

  1. Review

    1. Top of page
    2. Review
    3. Original Reports
    4. Brief Report
    5. Original Reports
    6. Letters to the Editor
    7. Erratum
  2. Original Reports

    1. Top of page
    2. Review
    3. Original Reports
    4. Brief Report
    5. Original Reports
    6. Letters to the Editor
    7. Erratum
    1. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury (pages 1155–1172)

      Charles E. Leonard, Cristin P. Freeman, Craig W. Newcomb, Peter P. Reese, Maximilian Herlim, Warren B. Bilker, Sean Hennessy and Brian L. Strom

      Version of Record online: 9 AUG 2012 | DOI: 10.1002/pds.3329

    2. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users (pages 1183–1189)

      Cécile Droz-Perroteau, Cécile Marchal, Caroline Dureau-Pournin, Régis Lassalle, Jérémy Jové, Philip Robinson, Gilles Lavernhe, Hervé Vespignani, Nicholas Moore, Annie Fourrier-Réglat and on behalf of the Eulev Study group

      Version of Record online: 13 SEP 2012 | DOI: 10.1002/pds.3338

    3. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 (pages 1190–1196)

      Claudio Bucolo, Laura Longo, Giovanni Camillieri, Filippo Drago and Salvatore Salomone

      Version of Record online: 31 JUL 2012 | DOI: 10.1002/pds.3328

    4. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies (pages 1202–1215)

      Vincent Lo Re III, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar and Brian L. Strom

      Version of Record online: 4 JUL 2012 | DOI: 10.1002/pds.3318

  3. Brief Report

    1. Top of page
    2. Review
    3. Original Reports
    4. Brief Report
    5. Original Reports
    6. Letters to the Editor
    7. Erratum
  4. Original Reports

    1. Top of page
    2. Review
    3. Original Reports
    4. Brief Report
    5. Original Reports
    6. Letters to the Editor
    7. Erratum
    1. Administered paricalcitol dose and survival in hemodialysis patients: A marginal structural model analysis (pages 1232–1239)

      Jessica E Miller, Miklos Z Molnar, Csaba P Kovesdy, Joshua J Zaritsky, Elani Streja, Isidro Salusky, Onyebuchi A Arah and Kamyar Kalantar-Zadeh

      Version of Record online: 20 SEP 2012 | DOI: 10.1002/pds.3349

  5. Letters to the Editor

    1. Top of page
    2. Review
    3. Original Reports
    4. Brief Report
    5. Original Reports
    6. Letters to the Editor
    7. Erratum
    1. Bupropion therapy in pregnancy and the occurrence of cardiovascular malformations in infants (pages 1240–1242)

      Veena Thyagarajan, C. Robin Clifford, Keele E. Wurst, Sara A. Ephross and John D. Seeger

      Version of Record online: 29 OCT 2012 | DOI: 10.1002/pds.3271

  6. Erratum

    1. Top of page
    2. Review
    3. Original Reports
    4. Brief Report
    5. Original Reports
    6. Letters to the Editor
    7. Erratum
    1. You have free access to this content
      Guidelines for Good Database Selection and use in Pharmacoepidemiology Research (page 1249)

      Gillian C. Hall, Brian Sauer, Alison Bourke, Jeffrey S. Brown, Matthew W. Reynolds and Robert Lo Casale

      Version of Record online: 29 OCT 2012 | DOI: 10.1002/pds.3343

      This article corrects:

      Guidelines for good database selection and use in pharmacoepidemiology research

      Vol. 21, Issue 1, 1–10, Version of Record online: 8 NOV 2011

SEARCH

SEARCH BY CITATION